Gynecology Drugs Market is Expected to Grow with a CAGR of 7.42% by 2026
Growing awareness about women’s health is driving the growth of Global Gynecology Drugs Market in the forecast period.
According to TechSci Research report, “Global Gynecology Drugs Market By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By Indication (Gynecology Cancers, Polycystic Ovary Syndrome, Contraception, Endometriosis, Female Infertility, Gynecology Infections, Postmenopausal Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2026”, the global gynecology drugs market is projected to grow at a CAGR of 7.42% and will reach USD20222.86 million by 2026 owing to rising incidences of gynecological diseases, change in lifestyle of the global female population, and rise in the demand for better gynecological treatments. Moreover, the increasing instances of chronic diseases like cancer is driving the growth of the global gynecology market in the next five years. However, stringent regulations and high-quality standards set by market leaders are projected to restrain the penetration of new entrants, which will eventually hinder the market growth.
Gynecology drugs are the therapeutic drugs that are conditioned for the treatments of gynecologic diseases. Gynecological disease is a medical condition affecting the female reproductive system. Gynecological diseases include cervical dysplasia, menstrual disorders, pelvic floor prolapse, pelvic pain, polycystic ovarian syndrome, uterine fibroids, urinary incontinence. Gynecology disorders may cause severe issues in case of pregnant women.
According to the World Health Organization, in 2020, between 2018 and 2030, the annual incidence rate of cervical cancer cases is predicted to rise from 570 000 to 700 000. The number of deaths each year is expected to climb from 311 000 to 400 000. It is roughly twice as common in low- and middle-income nations, with death rates three times higher than in high-income nations.
Browse over 108 market data Figures spread through 110 Pages and an in-depth TOC on “Global Gynecology Drugs Market”
https://www.techsciresearch.com/report/gynecology-drugs-market/7427.html
The global gynecology drugs market is segmented by therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on indication, the market is further fragmented into gynecology cancers, polycystic ovary syndrome, contraception, endometriosis, female infertility, gynecology infections, postmenopausal disorders. Amongst these, the Polycystic ovary syndrome segment is expected to lead the market in the forecast period.
Gynecology cancers are the type of cancers that are formed in the reproductive organs. Cases of cervical cancers, ovarian cancer, uterine cancer, vaginal cancer, vulvar cancer are all types of gynecology cancers that are prevailing in the last five years. Endometriosis is a disorder in which uterus tissues grow outside the uterus lining. These tissues outgrow over ovaries, fallopian tubes or the intestines. Female infertility is about the condition, where women lose the ability to procreate. In this procedure, the ovulation and menstrual cycles are irregular which means that the woman is not producing the ovarian eggs for the fertilization. Reproductive organ failure may lead to female infertility too. Menopausal disorder is the medical condition in which the female patient is affected by gynecological disorder after they experience their menopause.
Major companies in the market are Amgen Inc., F. Hoffmann-La Roche Ltd., Novartis Ltd., Bayer AG, Merck & Co., Inc., GlaxoSmithKline Plc, Sanofi SA, Eli Lilly and Company Ltd., Ferring Pharmaceuticals A/S, AstraZeneca Plc, TherapeuticsMD, Inc., AbbVie Inc., Abbott Laboratories Ltd., Lupin Pharmaceuticals, Inc., Pfizer Inc., among others. The market players are actively involved in the technological advancements of the therapeutics as well as research and development of the medical devices used for the administration of gynecology drugs. Other strategies include partnerships among the market players.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7427
Customers can also request for 10% free customization on this report.
“North America is a promising region for the future market owing to the excellent healthcare industry developments. Moreover, the US Food and Drug Administration (FDA) approval towards various therapeutics is driving the growth of the market consistently. Also, United States is the major economy that suffers due to the rising incidences of breast cancer, menopausal disorders, polycystic ovary syndrome and other chronical diseases related to women. Furthermore, working class women are a large population of the country, and the work environment is often stressful which causes severe issues in the gynae health. Also, issues like polycystic ovarian disorder are also rapidly increasing in the Asia Pacific region, thus the market is anticipated to grow at a significant share in the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Gynecology Drugs Market By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By Indication (Gynecology Cancers, Polycystic Ovary Syndrome, Contraception, Endometriosis, Female Infertility, Gynecology Infections, Postmenopausal Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global gynecology drugs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global gynecology drugs market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/
